OsteoBridge Intramedullary Diaphysis Segment Fixation (IDSF) nails (humerus)
FDA Device Recall #Z-0438-2021 — Class II — September 18, 2020
Recall Summary
| Recall Number | Z-0438-2021 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 18, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Merete Medical GmbH |
| Location | Berlin |
| Product Type | Devices |
| Quantity | 144 units |
Product Description
OsteoBridge Intramedullary Diaphysis Segment Fixation (IDSF) nails (humerus)
Reason for Recall
Product may be mislabeled.
Distribution Pattern
Product was distributed in US - CA, IL, MD, OH, and NJ
Lot / Code Information
Lot Number Use By Date MS1912994R 6/4/2025 MS1811555R 7/24/2025 MS1913023R 6/4/2025 MS1811556R 7/24/2025 MS1913024R 6/4/2025 MS1913024R 6/4/2025 MS1811557R 7/24/2025 MS1913027R 6/4/2025 MS1811585R 7/23/2025 MS1913028R 6/4/2025 MS1811604R 7/23/2025 MS1913029R 6/4/2025 MS1913029R 6/4/2025 MS1811605R 7/23/2025 MS1913038R 6/4/2025 MS1811606R 7/23/2025 MS1811607R 6/4/2025 MS1811607R1 7/23/2025 MS1913039R 6/4/2025 MS1811624R 7/23/2025 MS1811673R 6/4/2025 MS1811625R 7/23/2025 MS1811673R1 7/23/2025 MS1811634R 6/4/2025 MS1811634R1 7/23/2025 MS1913041R 6/4/2025 MS1811623R 7/24/2025 MS1913042R 6/4/2025 MS1811635R 7/24/2025 MS1913043R 6/4/2025 MS1913043R 6/4/2025 MS1811636R 7/24/2025
Other Recalls from Merete Medical GmbH
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0650-2022 | Class II | Merete PediatrOS RigidTack, REF CP20120, Size 2... | Jan 18, 2022 |
| Z-0437-2021 | Class II | OsteoBridge Intramedullary Diaphysis Segment Fi... | Sep 18, 2020 |
| Z-0435-2021 | Class II | OsteoBridge Intremedullary Knee Arthrodesis (IK... | Sep 18, 2020 |
| Z-0436-2021 | Class II | OsteoBridge Intramedullary Diaphysis Segment Fi... | Sep 18, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.